[HTML][HTML] Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Many nations are pursuing the rollout of SARS-CoV-2 vaccines as an exit strategy from
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
[HTML][HTML] Broadly-neutralizing antibodies against emerging SARS-CoV-2 variants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
have become a major concern in the containment of current pandemic. The variants …
have become a major concern in the containment of current pandemic. The variants …
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
D Geers, MC Shamier, S Bogers, G den Hartog… - Science …, 2021 - science.org
The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …
raised concern about potential immune escape. Here, we studied humoral and cellular …
[HTML][HTML] Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
RT Shroff, P Chalasani, R Wei, D Pennington… - Nature medicine, 2021 - nature.com
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
shown high efficacy, but immunocompromised participants were excluded from controlled …
shown high efficacy, but immunocompromised participants were excluded from controlled …
[PDF][PDF] Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
S Moriyama, Y Adachi, T Sato, K Tonouchi, L Sun… - Immunity, 2021 - cell.com
Antibody titers against SARS-CoV-2 slowly wane over time. Here, we examined how time
affects antibody potency. To assess the impact of antibody maturation on durable …
affects antibody potency. To assess the impact of antibody maturation on durable …
[HTML][HTML] Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
Abstract The CVnCoV (CureVac) mRNA vaccine for severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) was recently evaluated in a phase 2b/3 efficacy trial in …
coronavirus-2 (SARS-CoV-2) was recently evaluated in a phase 2b/3 efficacy trial in …
[HTML][HTML] SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
F Tea, A Ospina Stella, A Aggarwal… - PLoS …, 2021 - journals.plos.org
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody
neutralization response and its evasion by emerging viral variants and variant of concern …
neutralization response and its evasion by emerging viral variants and variant of concern …
[HTML][HTML] Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA …
Abstract Background Coronavirus SARS-CoV-2, the causative agent of COVID-19, has
caused a still evolving global pandemic. Given the worldwide vaccination campaign, the …
caused a still evolving global pandemic. Given the worldwide vaccination campaign, the …
COVID‐19 and plasma cells: Is there long‐lived protection?
DC Nguyen, PA Lamothe, MC Woodruff… - Immunological …, 2022 - Wiley Online Library
Summary Infection with SARS‐CoV‐2, the etiology of the ongoing COVID‐19 pandemic, has
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
TA Ikizler, PT Coates, BH Rovin, P Ronco - Kidney International, 2021 - Elsevier
In this issue of Kidney International, the initial experience regarding the immunogenicity of
prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 …
prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 …